In patients with pseudomyxoma peritonei, elevated tumor marker counts (including CA125, CA19-9, and CEA) were linked to poorer surgical outcomes and reduced survival [31,47]. This evidence concerns the gene CEACAM5 and pseudomyxoma peritonei.